News Center
——
News Center
Xingmin Zhang MD, Ph.D.
Time of issue：
2020-02-25
Author:
Origin:
Xingmin Zhang MD, Ph.D.
Founder, Chairman & CEO
M.D./Ph. D. in Rheumatology and Immunology from Peking Union Medical College Hospital, China Union Medical College in 1997.
Postdoctoral fellow and instructor at Brigham and Women’s Hospital, Harvard Medical School.
Associate principal scientist at Schering-Plough Corporation and then Merck & Co.
Dr. Zhang was the first to report the induction and activation of regulatory T cells (Treg cells) in animals. Besides clinical practice, he has more than 20-year experience in biomedical research and new drug development. Since 2004, he has led and participated in the R&D of a series of anti-inflammation and antitumor drugs. In 2018, Dr. Zhang founded BroadenBio Co., Ltd., serving as chairman and CEO.
previous page
next page
previous page
next page
address：
A1-602, 88 Kechuang 6th Street, BDA, Beijing 100176
phone：
Copyright ©2019 BroadenBio